Hikma US unit launches anti-depression tablets

Hikma Pharmaceuticals said its wholly-owned US subsidiary West-Ward Pharmaceuticals Corp. had launched its anti-depression tablets Pristiq (Desvenlafaxine Succinate).

Desvenlafaxine Succinate tablets are in a class of medications called selective serotonin and norepinephrine reuptake inhibitors, Hikma said on Friday.

US sales of Desvenlafaxine Succinate ER Tablets in 50 mg and 100 mg strengths were approximately $853m in the 12 months ending January 2017, according to health information group IMS.